No abstract available
MeSH terms
-
Cardiovascular Diseases / chemically induced*
-
Cardiovascular Diseases / drug therapy
-
Cardiovascular Diseases / prevention & control
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetic Cardiomyopathies / chemically induced
-
Diabetic Cardiomyopathies / drug therapy
-
Diabetic Cardiomyopathies / prevention & control
-
Europe
-
Government Agencies
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Myocardial Infarction / chemically induced*
-
Randomized Controlled Trials as Topic
-
Rosiglitazone
-
Thiazolidinediones / adverse effects*
-
Thiazolidinediones / therapeutic use
-
United States
-
United States Food and Drug Administration
Substances
-
Hypoglycemic Agents
-
Insulin
-
Thiazolidinediones
-
Rosiglitazone